Titre : Facteurs cord

Facteurs cord : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteurs cord : Questions médicales les plus fréquentes", "headline": "Facteurs cord : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteurs cord : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-17", "dateModified": "2025-04-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteurs cord" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Toxines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001427", "about": { "@type": "MedicalCondition", "name": "Toxines bactériennes", "code": { "@type": "MedicalCode", "code": "D001427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123" } } }, "about": { "@type": "MedicalCondition", "name": "Facteurs cord", "alternateName": "Cord Factors", "code": { "@type": "MedicalCode", "code": "D003311", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Qian Wu", "url": "https://questionsmedicales.fr/author/Qian%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Acupuncture and Moxibustion, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China." } }, { "@type": "Person", "name": "E Bárbara-Bataller", "url": "https://questionsmedicales.fr/author/E%20B%C3%A1rbara-Bataller", "affiliation": { "@type": "Organization", "name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain. Electronic address: ebb31604@hotmail.com." } }, { "@type": "Person", "name": "J L Méndez-Suárez", "url": "https://questionsmedicales.fr/author/J%20L%20M%C3%A9ndez-Su%C3%A1rez", "affiliation": { "@type": "Organization", "name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain." } }, { "@type": "Person", "name": "C Alemán-Sánchez", "url": "https://questionsmedicales.fr/author/C%20Alem%C3%A1n-S%C3%A1nchez", "affiliation": { "@type": "Organization", "name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain." } }, { "@type": "Person", "name": "P Peñaloza-Polo", "url": "https://questionsmedicales.fr/author/P%20Pe%C3%B1aloza-Polo", "affiliation": { "@type": "Organization", "name": "Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37511475", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241411715" } }, { "@type": "ScholarlyArticle", "name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.", "datePublished": "2023-03-07", "url": "https://questionsmedicales.fr/article/36894035", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1053/j.gastro.2023.02.044" } }, { "@type": "ScholarlyArticle", "name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.", "datePublished": "2023-02-28", "url": "https://questionsmedicales.fr/article/36855007", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12350-023-03202-w" } }, { "@type": "ScholarlyArticle", "name": "Optimal age to stop prostate cancer screening and early detection.", "datePublished": "2023-08-19", "url": "https://questionsmedicales.fr/article/37598870", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcpo.2023.100443" } }, { "@type": "ScholarlyArticle", "name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36121650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijc.34298" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Toxines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001427" }, { "@type": "ListItem", "position": 5, "name": "Facteurs cord", "item": "https://questionsmedicales.fr/mesh/D003311" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteurs cord - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteurs cord", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteurs cord", "description": "Comment diagnostiquer une infection par Cord Factors ?\nQuels tests sont utilisés pour détecter les Cord Factors ?\nLes Cord Factors sont-ils visibles sur une radiographie ?\nPeut-on identifier les Cord Factors par PCR ?\nQuels symptômes peuvent indiquer une infection par Cord Factors ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteurs cord", "description": "Quels sont les symptômes d'une infection par Cord Factors ?\nLes Cord Factors provoquent-ils des symptômes immédiats ?\nY a-t-il des symptômes spécifiques aux Cord Factors ?\nComment les symptômes évoluent-ils avec les Cord Factors ?\nLes Cord Factors causent-ils des douleurs thoraciques ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteurs cord", "description": "Comment prévenir une infection par Cord Factors ?\nLa vaccination est-elle efficace contre les Cord Factors ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir l'infection par Cord Factors ?\nLes tests de dépistage sont-ils importants pour la prévention ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteurs cord", "description": "Quel est le traitement standard pour une infection par Cord Factors ?\nLes Cord Factors nécessitent-ils un traitement prolongé ?\nY a-t-il des traitements alternatifs pour les Cord Factors ?\nLes Cord Factors sont-ils résistants aux antibiotiques ?\nComment surveiller l'efficacité du traitement des Cord Factors ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteurs cord", "description": "Quelles complications peuvent survenir avec les Cord Factors ?\nLes Cord Factors peuvent-ils causer des infections systémiques ?\nComment les complications affectent-elles le traitement ?\nLes complications sont-elles fréquentes avec les Cord Factors ?\nQuelles sont les conséquences à long terme des Cord Factors ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteurs cord", "description": "Quels sont les principaux facteurs de risque pour les Cord Factors ?\nLe VIH augmente-t-il le risque d'infection par Cord Factors ?\nLes personnes âgées sont-elles plus à risque ?\nLe voyage dans des zones endommagées augmente-t-il le risque ?\nLe contact avec des personnes infectées est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Cord Factors ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests microbiologiques et des cultures de Mycobacterium." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les Cord Factors ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture et des tests sérologiques peuvent être utilisés pour détecter les Cord Factors." } }, { "@type": "Question", "name": "Les Cord Factors sont-ils visibles sur une radiographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, les Cord Factors ne sont pas visibles sur une radiographie, mais les effets de l'infection le sont." } }, { "@type": "Question", "name": "Peut-on identifier les Cord Factors par PCR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la PCR peut être utilisée pour identifier les gènes associés aux Cord Factors." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une infection par Cord Factors ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux persistante, fièvre, et perte de poids, mais varient selon l'individu." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par Cord Factors ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, fièvre, sueurs nocturnes et fatigue, souvent liés à la tuberculose." } }, { "@type": "Question", "name": "Les Cord Factors provoquent-ils des symptômes immédiats ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent prendre du temps à apparaître après l'infection initiale." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux Cord Factors ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes sont généralement ceux de la tuberculose, sans spécificité pour les Cord Factors." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec les Cord Factors ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec le temps si l'infection n'est pas traitée." } }, { "@type": "Question", "name": "Les Cord Factors causent-ils des douleurs thoraciques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs thoraciques peuvent survenir en raison de l'infection pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir une infection par Cord Factors ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut la vaccination BCG et des mesures d'hygiène pour éviter la transmission." } }, { "@type": "Question", "name": "La vaccination est-elle efficace contre les Cord Factors ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG peut réduire le risque de tuberculose, mais n'est pas toujours efficace." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter le contact avec des personnes infectées sont essentiels." } }, { "@type": "Question", "name": "Les masques aident-ils à prévenir l'infection par Cord Factors ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter un masque peut réduire le risque de transmission dans les zones à risque." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils importants pour la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce permet d'identifier et de traiter les infections rapidement." } }, { "@type": "Question", "name": "Quel est le traitement standard pour une infection par Cord Factors ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des antibiotiques comme l'isoniazide et la rifampicine." } }, { "@type": "Question", "name": "Les Cord Factors nécessitent-ils un traitement prolongé ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement peut durer plusieurs mois pour éradiquer complètement l'infection." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs pour les Cord Factors ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs existent, mais ils doivent être prescrits par un médecin." } }, { "@type": "Question", "name": "Les Cord Factors sont-ils résistants aux antibiotiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines souches de Mycobacterium peuvent développer une résistance aux antibiotiques." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement des Cord Factors ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est surveillée par des tests de culture et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les Cord Factors ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la pneumonie, la pleurésie et la dissémination de l'infection." } }, { "@type": "Question", "name": "Les Cord Factors peuvent-ils causer des infections systémiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une infection non traitée peut se propager et causer des infections systémiques graves." } }, { "@type": "Question", "name": "Comment les complications affectent-elles le traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent rendre le traitement plus complexe et prolonger la durée de la thérapie." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes avec les Cord Factors ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont possibles, surtout si l'infection n'est pas traitée rapidement." } }, { "@type": "Question", "name": "Quelles sont les conséquences à long terme des Cord Factors ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure des lésions pulmonaires permanentes et des problèmes respiratoires." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les Cord Factors ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent l'immunodépression, le tabagisme et la malnutrition." } }, { "@type": "Question", "name": "Le VIH augmente-t-il le risque d'infection par Cord Factors ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le VIH affaiblit le système immunitaire, augmentant le risque d'infection tuberculeuse." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Le voyage dans des zones endommagées augmente-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à forte prévalence de tuberculose augmente le risque d'infection." } }, { "@type": "Question", "name": "Le contact avec des personnes infectées est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le contact étroit avec des personnes infectées augmente le risque de transmission." } } ] } ] }

Sources (10000 au total)

A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.

Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv... The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro... In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo... EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....

Optimal age to stop prostate cancer screening and early detection.

Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can... We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer... Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the... Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...

Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer.

The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can... This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ... In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst... Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...

Integration of multiomics features for blood-based early detection of colorectal cancer.

Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o... In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me... This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv... Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...

Prospective cohort for early detection of liver cancer (Pearl): a study protocol.

Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir... This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ... Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings.... NCT05541601....